Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CEO
Research
Charles River's incoming CEO talks R&D processes, reorg goals
Charles River's incoming CEO sees animal-sparing research as “an evolution” of the industry's current R&D methodologies.
Fraiser Kansteiner
Jan 28, 2026 12:58pm
Longtime Charles River CEO to retire; COO will take the helm
Jan 8, 2026 12:54pm
Fierce Pharma
Amgen obesity marketing head Boulton departs to lead Prolynx
Dec 11, 2025 10:40am
Olympus-backed Swan EndoSurgical taps Stryker vet for CEO
Dec 3, 2025 9:20am
Novocure replaces CEO after less than a year
Dec 2, 2025 9:35am
82% of industry CEOs concerned about FDA's abilities: survey
Nov 21, 2025 4:38pm
